Skip to content

SpO2 Hypoxia Accuracy Validation Study

SpO2 Hypoxia Accuracy Validation Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03348189
Enrollment
12
Registered
2017-11-20
Start date
2017-11-01
Completion date
2017-11-03
Last updated
2017-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxia

Brief summary

The primary objective of this study is to evaluate the % oxygen saturation by pulse oximetry accuracy of a combined pulse oximetry system which consists of a Nonin sensor ), an adaptor cable, and an oximetry system during non-motion conditions.

Detailed description

The primary objective of this study is to evaluate the %SpO2 accuracy of a combined pulse oximetry system which consists of a Nonin sensor ), an adaptor cable, and an oximetry system during non-motion conditions.

Interventions

OTHERPulse Oximeter

Pulse Oximeter

Sponsors

Nonin Medical, Inc
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* The subject is male or female * The subject is of any racial or ethnic group * The subject is ≥ 30 kg (≥ 66 pounds) in weight (self-reported) * The subject has at least one finger height of 0.2 - 1.0 inch (based on measurement) * The subject is between 18 years and 50 years of age (self-reported) * The subject shows no evidence of medical problems as indicated by satisfactory completion of the health assessment form * The subject has given written informed consent to participate in the study * The subject is both willing and able to comply with study procedures.

Exclusion criteria

* The subject has a BMI greater than 31 (based on weight and height) * The subject has had any relevant injury at the sensor location site (self-reported) * The subject has deformities or abnormalities that may prevent proper application of the device under test (based on examination) * The subject is current smoker (self-reported) * The subject has a known respiratory condition (self-reported) * The subject has a known heart or cardiovascular condition (self-reported) * The subject is currently pregnant, is actively trying to get pregnant, or who has a positive urine pregnancy test on the day of the study * The subject has a clotting disorder (self-reported) * The subject has Raynaud's Disease (self-reported) * The subject is known to have a hemoglobinopathy (self-reported) * The subject is on blood thinners or medication with aspirin (self-reported) * The subject has unacceptable collateral circulation from the ulnar artery (based on examination) * The subject is unwilling or unable to provide written informed consent to participate in the study * The subject is unwilling or unable to comply with the study procedures * The subject has another health condition which in the opinion of the principal investigator makes him/her unsuitable for testing.

Design outcomes

Primary

MeasureTime frameDescription
SpO2 Hypoxia Accuracy Validation StudyThrough study completion, 3 months averageValues from the test device will be compared to the values from co-oximetry to determine accuracy of the test device.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026